Abstract
Chronic Kidney Disease (CKD) prevalence has increased worldwide. Cardiovascular disease is the main cause of mortality in this population. The use of glucose in the peritoneal dialysis (PD) fluid is expected to worsen the patient's lipid profile, already altered by the CKD itself. The HDL (high-density lipoprotein) molecule can change under these conditions, not only in its quantity but a…